Viewing Study NCT03024034


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-02-22 @ 4:13 AM
Study NCT ID: NCT03024034
Status: COMPLETED
Last Update Posted: 2021-12-13
First Post: 2017-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 TP-271 Oral PK Single Ascending Dose Study
Sponsor: Tetraphase Pharmaceuticals, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module